Clinical Trials Browser

Phase 4 × camrelizumab × Thoracic × Clear all

NCT06276933 2024-02-26

A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 4 Not yet recruiting

Lung Neoplasms